Introduction: In malaria treatment protocols, treatment failure or drug resistance of synthesized drugs like alkaloids related to quinine, and aminoquinolines are the main problems now. Therefore, discovering efficient drugs or combination therapy of blood schizonticidal drugs with different mechanisms or different targets in the parasite is a crucial effort to solve this problem. In this study, the effectiveness of Crocus sativus Stigma (saffron) individually and in combination with chloroquine, was considered against chloroquine–sensitive strain of Plasmodium berghei.Methods: At the first stage, using 4 day suppressive Peter’s test in mice, ED50 and survival times of saffron methanol extract, and its aqueous and ethyl acetate ...
Background: Resistance to most antimalarial drugs has encouraged the use of herbal preparations alon...
© Cambridge University Press 2016We report the pharmacological activity of organoruthenium complexes...
Piperaquine is being developed as a long-acting component in artemisinin combination therapies. It w...
Background: The emergence and spread of Plasmodium berghei with resistance to chloroquine (CQ), the ...
 Objective: The aim was to determine the antimalarial drug effectiveness of the combination therapy...
Purpose: Antihistamine H1 receptor antagonists like promethazine (PR) are capable of reversing resis...
There is an increasing need for innovative drug and prophylaxis discovery against malaria. The aim o...
Objective: The aim was to determine the antimalarial drug effectiveness of the combination therapy m...
Background: Malaria is one of the greatest health challenges worldwide threatening millions of peopl...
AbstractObjectiveTo determine the suppressive and curative activity of aqueous leaf extract of Agera...
In malarial endemic countries especially in the tropics, conventional antimalarial drugs are used wi...
Artemisinin-based combination (ACT) therapy is the mainstay for malaria treatment. However, Plasmodi...
Research Article published by DovepressBackground: The search for new antimalarial drugs has become ...
The ethanolic leaf extract of Hyptis suaveolens was evaluated for antimalarial activity against Plas...
Background: The emergence and spread of Plasmodium falciparum with resistance to chloroquine (CQ), t...
Background: Resistance to most antimalarial drugs has encouraged the use of herbal preparations alon...
© Cambridge University Press 2016We report the pharmacological activity of organoruthenium complexes...
Piperaquine is being developed as a long-acting component in artemisinin combination therapies. It w...
Background: The emergence and spread of Plasmodium berghei with resistance to chloroquine (CQ), the ...
 Objective: The aim was to determine the antimalarial drug effectiveness of the combination therapy...
Purpose: Antihistamine H1 receptor antagonists like promethazine (PR) are capable of reversing resis...
There is an increasing need for innovative drug and prophylaxis discovery against malaria. The aim o...
Objective: The aim was to determine the antimalarial drug effectiveness of the combination therapy m...
Background: Malaria is one of the greatest health challenges worldwide threatening millions of peopl...
AbstractObjectiveTo determine the suppressive and curative activity of aqueous leaf extract of Agera...
In malarial endemic countries especially in the tropics, conventional antimalarial drugs are used wi...
Artemisinin-based combination (ACT) therapy is the mainstay for malaria treatment. However, Plasmodi...
Research Article published by DovepressBackground: The search for new antimalarial drugs has become ...
The ethanolic leaf extract of Hyptis suaveolens was evaluated for antimalarial activity against Plas...
Background: The emergence and spread of Plasmodium falciparum with resistance to chloroquine (CQ), t...
Background: Resistance to most antimalarial drugs has encouraged the use of herbal preparations alon...
© Cambridge University Press 2016We report the pharmacological activity of organoruthenium complexes...
Piperaquine is being developed as a long-acting component in artemisinin combination therapies. It w...